Ads
related to: abbvie upadacitinib atopic dermatitis- Real Patient Testimonials
Learn About Actual RINVOQ®
Patient Experiences. See Videos.
- RINVOQ® Complete
Get Access To Prescription Savings
And Insurance Coverage Info.
- Find A Doctor
Ask Your Doctor If RINVOQ®
Is The Right Treatment For You.
- Register For More Info
Sign Up For More
Information About RINVOQ®.
- Important Safety Info
Read The Full Safety
& Prescribing Info For RINVOQ®.
- See The Results
View Results From
Clinical Trials.
- Real Patient Testimonials
Search results
AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
Zacks via Yahoo Finance· 7 months agoAbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...
Here's How Much You'd Have If You Invested $1000 in AbbVie a Decade Ago
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is important for most investors, since price performance...
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV announced that the European Medicines Agency’s Committee for Medicinal Products for...
AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) has several new drugs with the potential to drive revenues once Humira loses U.S....
AbbVie's (ABBV) Rinvoq Gets FDA Nod to Treat Crohn's Disease
Zacks via Yahoo Finance· 1 year agoAbbVie (ABBV) announces the seventh FDA approval of its JAK inhibitor, Rinvoq, for the treatment of...
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new...
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – March 27, 2023 – Zacks.com announces the list of stocks featured...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
Zacks via Yahoo Finance· 10 months agoThis week, AstraZeneca AZN, Sanofi SNY and AbbVie ABBV and Roche announced second-quarter earnings....
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 1 month agoThis week, J&J JNJ began the first-quarter 2024 earnings season for the pharma space with mixed...
Lilly (LLY), Incyte's Olumiant Gets FDA Nod for Alopecia Areata
Zacks via Yahoo Finance· 2 years agoEli Lilly LLY and partner Incyte INCY announced that the FDA has granted approval to their oral JAK...
Ads
related to: abbvie upadacitinib atopic dermatitis